Bertin Bioreagent

anti-TAF7 (formerly TAFII55), mAb (2C7)

As low as CHF 664.00
In stock
Only %1 left
BRT-G01087-R100100 µlCHF 664.00
 

Specifications / Handling

More Information
Product Details
Synonyms Transcription Initiation Factor TFIID Subunit 7; TATA-Box Binding Protein-Associated Factor 7; TAFII55; RNA Polymerase II TBP-associated Factor Subunit F
Product Type Monoclonal Antibody
Properties
Clone 2C7
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Recombinant human TAF7 protein.
Application ELISA, Western Blot, Immunoprecipitation, Immunocytochemistry. Recommended dilutions: 1/500-1/5000.
Specificity Recognizes human and mouse TAF7.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description
TAF7 is a transcription cofactor that is a part of the TFIID complex, which plays an essential role in RNA polymerase II-dependent transcription initiation. It contributes to the regulation of gene expression by stabilizing and assisting in the formation of the TFIID complex, which is required for initiating transcription at core promoters. TAF7 is a core subunit of the TFIID complex, which is responsible for recognizing core promoter sequences (such as the TATA box) and recruiting RNA polymerase II to initiate transcription. It is involved in the recruitment of transcription factors and coactivators that are necessary for gene-specific transcriptional activation. TAF7 plays a critical role in gene regulation during development, particularly in embryonic development and cell differentiation. Dysregulation of transcription initiation can lead to abnormal gene expression, particularly genes involved in cell proliferation, survival, and apoptosis, which may promote tumorigenesis.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.